221 related articles for article (PubMed ID: 19670076)
1. Final results of a long-term, clinical follow-up in fatty liver patients.
Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
[TBL] [Abstract][Full Text] [Related]
2. Long-term, clinical follow-up in fatty liver patients.
Bendtsen F; Dam-Larsen S
Dig Dis; 2010; 28(6):709-14. PubMed ID: 21525754
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
Ekstedt M; Franzén LE; Mathiesen UL; Thorelius L; Holmqvist M; Bodemar G; Kechagias S
Hepatology; 2006 Oct; 44(4):865-73. PubMed ID: 17006923
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen P; Vilstrup H; Mellemkjaer L; Thulstrup AM; Olsen JH; Baron JA; Sørensen HT
Hepatogastroenterology; 2003; 50(54):2101-4. PubMed ID: 14696473
[TBL] [Abstract][Full Text] [Related]
6. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.
Söderberg C; Stål P; Askling J; Glaumann H; Lindberg G; Marmur J; Hultcrantz R
Hepatology; 2010 Feb; 51(2):595-602. PubMed ID: 20014114
[TBL] [Abstract][Full Text] [Related]
7. Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.
Rakha EA; Adamson L; Bell E; Neal K; Ryder SD; Kaye PV; Aithal GP
J Clin Pathol; 2010 Sep; 63(9):790-5. PubMed ID: 20819880
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.
Friis-Liby I; Aldenborg F; Jerlstad P; Rundström K; Björnsson E
Scand J Gastroenterol; 2004 Sep; 39(9):864-9. PubMed ID: 15513385
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
Önnerhag K; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
[TBL] [Abstract][Full Text] [Related]
10. Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.
Semb S; Neermark S; Dam-Larsen S; Franzmann MB; Albrectsen J; Kallemose T; Becker U; Bendtsen F
Scand J Gastroenterol; 2016 Nov; 51(11):1367-74. PubMed ID: 27381376
[TBL] [Abstract][Full Text] [Related]
11. Low incidence of non-alcoholic steatohepatitis in a Danish liver unit.
Semb S; Dam-Larsen S; Mogensen AM; Albrectsen J; Bendtsen F
Dan Med J; 2012 Jan; 59(1):A4354. PubMed ID: 22239839
[TBL] [Abstract][Full Text] [Related]
12. ASH and NASH.
Scaglioni F; Ciccia S; Marino M; Bedogni G; Bellentani S
Dig Dis; 2011; 29(2):202-10. PubMed ID: 21734385
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
14. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
Deleuran T; Grønbaek H; Vilstrup H; Jepsen P
Aliment Pharmacol Ther; 2012 Jun; 35(11):1336-42. PubMed ID: 22490057
[TBL] [Abstract][Full Text] [Related]
17. Histological characteristics and prognosis in patients with fatty liver.
Dam-Larsen S; Franzmann MB; Christoffersen P; Larsen K; Becker U; Bendtsen F
Scand J Gastroenterol; 2005 Apr; 40(4):460-7. PubMed ID: 16028442
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
Domanski JP; Park SJ; Harrison SA
J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
20. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
